UNCOVERED: Telomir pharmaceuticals - The Untold Story

Telomir Pharmaceuticals Touts Promising Action From Its Lead Breast Cancer Drug

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) stock is trading higher on Thursday, with a session volume of 21.60 million compared to the average volume of 4.9 million, as per data from Benzinga Pro.

Benzinga · Oct 9, 2025

Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket

Shares of Telomir Pharmaceuticals Inc (NASDAQ:TELO) rose sharply in pre-market trading after the company released promising preclinical study results for its lead compound, Telomir-1.

Benzinga · Oct 7, 2025

McCormick, Telomir Pharmaceuticals And 3 Stocks To Watch Heading Into Tuesday

With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Benzinga · Oct 7, 2025